Qingdao Baheal Medical INC.
Qingdao Baheal Medical INC. engages in the research and development, production, wholesale, and retail of pharmaceutical products in China, the United States, Hong Kong, and the United Kingdom. The company offers bone health drugs under the D-Cal brand name; digestive drugs under the Mite brand name; liver disease drugs under the Fuzhenghuayu brand name; and urological drugs under the Betanli, Ha… Read more
Qingdao Baheal Medical INC. (301015) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.083x
Based on the latest financial reports, Qingdao Baheal Medical INC. (301015) has a cash flow conversion efficiency ratio of 0.083x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥230.38 Million) by net assets (CN¥2.76 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Qingdao Baheal Medical INC. - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Qingdao Baheal Medical INC.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Qingdao Baheal Medical INC. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qingdao Baheal Medical INC. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Microvast Holdings Inc
NASDAQ:MVST
|
0.042x |
|
Ning Xia Yin Xing Energy Co Ltd
SHE:000862
|
0.187x |
|
JK Lakshmi Cement Limited
NSE:JKLAKSHMI
|
0.095x |
|
NGERN TID LOR-NVDR- BA37
F:70V0
|
N/A |
|
Nagacorp Ltd
PINK:NGCRF
|
0.072x |
|
KSB Ltd
NSE:KSB
|
0.001x |
|
DIGITAL CORE REIT
PINK:DGTCF
|
N/A |
|
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
|
0.052x |
Annual Cash Flow Conversion Efficiency for Qingdao Baheal Medical INC. (2018–2024)
The table below shows the annual cash flow conversion efficiency of Qingdao Baheal Medical INC. from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.60 Billion | CN¥813.85 Million | 0.312x | +35.41% |
| 2023-12-31 | CN¥2.64 Billion | CN¥609.70 Million | 0.231x | +70.18% |
| 2022-12-31 | CN¥2.28 Billion | CN¥309.05 Million | 0.136x | +60.04% |
| 2021-12-31 | CN¥2.17 Billion | CN¥184.20 Million | 0.085x | +212.01% |
| 2020-12-31 | CN¥1.50 Billion | CN¥-113.36 Million | -0.076x | -314.83% |
| 2019-12-31 | CN¥1.31 Billion | CN¥45.96 Million | 0.035x | -31.18% |
| 2018-12-31 | CN¥1.08 Billion | CN¥55.50 Million | 0.051x | -- |